[Pathophysiology of multiple sclerosis]
- PMID: 16948217
[Pathophysiology of multiple sclerosis]
Abstract
Patients with multiple sclerosis (MS) can exhibit an exceptionally wide variety of symptoms. This is largely due to the semi-random distribution of the lesions in the central nervous system (CNS). Most lesions occur in apparently "silent" areas in the brain, and so cause no detectable symptoms. The disease is therefore much more active than a mere clinical monitoring would suggest. Most symptoms are related to a loss of function. During the relapses, this is due to a failure of axonal conduction at the site of the lesion(s). The conduction block is caused by the local demyelination which prevents the saltatory conduction but also seemingly, to some extend, by the inflammation per se. Remissions are related to a recovery of function of the affected axons owing to a spreading of sodium channels along the demyelinated axolemma but also to cerebral functional plasticity and remyelination. However, nerve conduction remains slower and less secure than normal, easily altered by physico-chemical changes such as the increase in body temperature (Uhthoff's phenomenon). Remission is incomplete when the lesion has led to axonal transaction and therefore axonal loss. Progression in MS is mainly related to "slow-burning" diffuse and chronic axonal loss in a toxic inflammatory milieu. Lastly, some symptoms in MS are so-called "positive" arising from an acquired hyperexcitability of demyelinated axons and occur either spontaneously (e.g. paresthesias) or mechanically (e.g. Lhermitte's sign).
Similar articles
-
The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease.Philos Trans R Soc Lond B Biol Sci. 1999 Oct 29;354(1390):1649-73. doi: 10.1098/rstb.1999.0510. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10603618 Free PMC article. Review.
-
Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis.Brain. 2006 Dec;129(Pt 12):3186-95. doi: 10.1093/brain/awl144. Epub 2006 Jun 9. Brain. 2006. PMID: 16766541
-
Changes in the expression and localization of the paranodal protein Caspr on axons in chronic multiple sclerosis.Brain. 2003 Jul;126(Pt 7):1638-49. doi: 10.1093/brain/awg151. Epub 2003 Apr 22. Brain. 2003. PMID: 12805111
-
Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.Neurology. 2008 Mar 25;70(13 Pt 2):1098-106. doi: 10.1212/01.wnl.0000291009.69226.4d. Epub 2008 Feb 20. Neurology. 2008. PMID: 18287569
-
Sodium channels as molecular targets in multiple sclerosis.J Rehabil Res Dev. 2002 Mar-Apr;39(2):233-42. J Rehabil Res Dev. 2002. PMID: 12051467 Review.
Cited by
-
Smouldering multiple sclerosis: the 'real MS'.Ther Adv Neurol Disord. 2022 Jan 25;15:17562864211066751. doi: 10.1177/17562864211066751. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35096143 Free PMC article. Review.
-
Medicinal herbal remedies in neurodegenerative diseases: an update on antioxidant potential.Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5483-5511. doi: 10.1007/s00210-024-03027-5. Epub 2024 Mar 13. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38472370 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical